(Q45712588)

15 December 2017

title

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study (English)

1 reference

15 December 2017

1 reference

1 reference

Nikolas von Bubnoff

1

1 reference

15 December 2017

Folker Schneller

series ordinal

2

1 reference

15 December 2017

Christian Peschel

series ordinal

3

1 reference

15 December 2017

Justus Duyster

series ordinal

4

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

15 December 2017

1 reference

15 December 2017

volume

359

1 reference

15 December 2017

issue

9305

1 reference

15 December 2017

page(s)

487-491

1 reference

The biology of chronic myeloid leukemia

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907679-1

7 January 2021

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907679-1

7 January 2021

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907679-1

7 January 2021

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907679-1

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907679-1

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907679-1

7 January 2021

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907679-1

7 January 2021

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907679-1

7 January 2021

Roots of clinical resistance to STI-571 cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907679-1

7 January 2021

10.1016/S0140-6736(02)07679-1

Identifiers

DOI

1 reference

15 December 2017

1 reference